Immunic market cap

Author: csqz

August undefined, 2024

Witryna1 dzień temu · Detailed statistics for Immunic, Inc. (IMUX) stock, including valuation metrics, financial numbers, share information and more. ... Immunic has a market … Witryna10 kwi 2024 · A high-level overview of Immunic, Inc. (IMUX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Immunic Reports Positive Data from Maintenance Phase of Phase …

WitrynaContact Email [email protected]. Phone Number +4989208047700. Immunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The company is developing three small molecule products; its lead development program, … WitrynaCurrent and historical total assets on balance sheet for Immunic. companies: 7,318 total market cap: $84.336 T. Global ranking; Ranking by countries. America ... The … simplicity\u0027s 1i

Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani Group were overblown by Hindenburg Research, the ... Witryna10 godz. temu · Mark Mobius, seasoned investor and founder of Mobius Capital, believes that the concerns around the Indian ports-to-energy conglomerate Adani … simplicity\u0027s 1h

Immunic, Inc. Reports Third Quarter 2024 Financial Results and

Witryna10 paź 2024 · NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX) ("Immunic" or the "Company"), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology ... Witryna12 kwi 2024 · The company has been renamed Immunic, Inc. and its common stock is expected to commence trading on The Nasdaq Capital Market under the ticker symbol "IMUX" on April 15, 2024. Immunic, Inc. is a ... simplicity\\u0027s 1mWitryna10 kwi 2024 · At the end of the latest market close, Immunic Inc. (IMUX) was valued at $1.55. In that particular session, Stock kicked-off at the price of $1.54 while reaching the peak value of $1.55 and lowest value recorded on the day was $1.36. The stock current value is $1.39.Recently in News on April 5, 2024 simplicity\u0027s 1j

"Witryna17 lis 2024 · November 17, 2024. NEW YORK, Nov. 17, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, today announced the formation of a Scientific-Medical … " - Immunic market cap

Immunic market cap

IMUX Immunic Inc. Stock Price & News - WSJ

Witryna3 lis 2024 · Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update. News provided by. Immunic, Inc. Nov 03, 2024, 06:30 ET. – $72.8 Million in Cash and Cash Equivalents as ... Witryna26 mar 2024 · 6.5%. 10% most volatile stocks in US Market. 16.6%. 10% least volatile stocks in US Market. 3.0%. Stable Share Price: IMUX is more volatile than 75% of US …

Did you know?

Witryna23 lut 2024 · NEW YORK, February 23, 2024 - Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small … Witryna14 kwi 2024 · Immunic Inc (IMUX) is down -5.26%% today. IMUX has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on IMUX!See Full IMUX ReportIMUX stock closed at $1.52 ...

WitrynaMarket Cap. $59.1M. Currency in USD. Quote data delayed by at least 15 minutes. Immunic, Inc. 1200 Avenue of the Americas Suite 200 New York, NY 10036, USA Phone: +1 332 2559811 Email: [email protected]. Immunic AG. Lochhamer Schlag 21 82166 Gräfelfing Germany Phone: +49 89 2080 477 00 Email: [email protected]. Witryna7 sty 2024 · Vital Therapies and Immunic will host a conference call at 8:00 a.m. ET on January 7, to discuss the proposed transaction. The conference call may be accessed by dialing +1 (855) 765-5682 for U.S ...

WitrynaAktien, Aktienkurse, Devisenkurse und Währungsrechner, Rohstoffkurse. Informationen rund um die Börse zu Aktie, Fonds und ETFs. Börsenkurse für Optionsscheine und Zertifikate. Aktienanalysen - finanzen.net Witryna2 dni temu · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive …

WitrynaImmunic Therapeutics has raised a total of $284.4M in funding over 9 rounds. Their latest funding was raised on Oct 10, 2024 from a Post-IPO Equity round. Immunic Therapeutics is registered under the ticker NASDAQ:IMUX . Immunic Therapeutics is funded by 21 investors. Vivo Capital and RTW Investments are the most recent …

Witryna10 sie 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] Or. Rx Communications Group Melody Carey +1-917-322-2571 [email protected] SOURCE ... raymond flaut brooklyn nyWitryna6 kwi 2024 · Immunic to Host Virtual Celiac Disease R&D Day to Highlight Current Pathways for Drug Development and Unmet Medical Need – Conference Call and Webcast to be Held Today, February 9, 2024, at 11:00 am ET – NEW YORK , Feb. 9, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage … simplicity\\u0027s 1oWitryna12 kwi 2024 · GSK PLC (LSE:GSK, NYSE:GSK)’s growth outlook is being overlooked and the worst-case scenario for Zantac continues to be reflected in the share price. That’s the view of Shore Capital which reiterated a buy on the pharma giant with a 1,850p share price target. The broker thinks GSK has made some steady inroads to … raymond fleuryWitryna15 kwi 2024 · Stock split history for Immunic (IMUX) Immunic stock (symbol: IMUX) underwent a total of 1 stock split. The stock split occured on April 15th, 2024. ... The … simplicity\u0027s 1oWitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 … raymond fletcher mpWitrynaChardan Capital Markets: Buy: $40: Show Previous Ratings Apr-13-23 08:00AM: Immunic gets a "positive surprise" from lead asset trial. News Direct. Apr-06-23 02:10PM: Immunic's (IMUX) Ulcerative Colitis Study Shows Positive Data ... Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral … raymond flint berkley maWitryna31 mar 2024 · Immunic has a market cap or net worth of $66.16 million as of April 1, 2024. Its market cap has decreased by -79.28% in one year. Market Cap 66.16M. … raymond flood